Quick Answer
Connect Biopharma Holdings Ltd reported Revenue From Contract With Customer Excluding Assessed Tax of $64.0 thousand for the year ending 2025.
- Connect Biopharma Holdings Ltd showed a decrease of -99.8% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from Connect Biopharma Holdings Ltd's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $64.0 thousand | Fiscal year 2024: $26.03 million | Fiscal year 2023: $0.00.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: